InfuSystem Holdings (INFU) Free Cash Flow (2010 - 2026)
InfuSystem Holdings (INFU) posted Free Cash Flow of $813000.0 for Q1 2026, down 81.77% on a QoQ basis from $4.5 million in Q4 2025, and down 67.6% year-over-year from $2.5 million in Q1 2025.
InfuSystem Holdings (INFU) Free Cash Flow (2010 - 2026) Analysis & Trends
InfuSystem Holdings' Free Cash Flow history runs 17 years deep, the most recent figure standing at $813000.0 for Q1 2026.
- Quarterly Free Cash Flow fell 67.6% year-over-year to $813000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $19.6 million (down 18.83% YoY) and the FY2025 annual result came in at $21.3 million, down 4.9% from the prior year.
- Free Cash Flow was $813000.0 for Q1 2026 at InfuSystem Holdings, down from $4.5 million in the prior quarter.
- Across five years, Free Cash Flow topped out at $11.5 million in Q3 2024 and bottomed at -$468000.0 in Q1 2023.
- A 5-year average of $4.2 million and a median of $3.2 million in 2022 frame the typical range for Free Cash Flow.
- Annual changes were most pronounced in 2023 — Free Cash Flow sank 111.59% — and 2024, when it soared 368.54%.
- InfuSystem Holdings' Free Cash Flow stood at $3.2 million in 2022, then jumped by 107.51% to $6.7 million in 2023, then soared by 30.3% to $8.7 million in 2024, then sank by 49.02% to $4.5 million in 2025, then tumbled by 81.77% to $813000.0 in 2026.
- Business Quant data shows INFU's Free Cash Flow at $813000.0 in Q1 2026, $4.5 million in Q4 2025, and $8.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.32 Bn | 174.03 Bn | 6.27 Bn | 916.00 Mn |
| 2 | Stryker | 128.59 Bn | 125.71 Bn | 3.81 Bn | 415.00 Mn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 2.09 Bn |
| 4 | Boston Scientific | 67.77 Bn | 66.32 Bn | 3.61 Bn | 171.00 Mn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.46 Bn | 1.29 Bn | -21.10 Mn |
| 6 | GE HealthCare Technologies | 28.44 Bn | 26.15 Bn | 1.98 Bn | 112.00 Mn |
| 7 | Dexcom | 28.41 Bn | 27.29 Bn | 750.30 Mn | 449.00 Mn |
| 8 | Smith & Nephew | 26.77 Bn | 26.20 Bn | - | - |
| 9 | Koninklijke Philips | 25.24 Bn | 22.11 Bn | 2.07 Bn | 305.56 Mn |
| 10 | InfuSystem Holdings | 191.92 Mn | 189.82 Mn | 19.68 Mn | 813,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 813,000.00 |
| Mar 31, 2026 | 813,000.00 |
| Dec 31, 2025 | 4.46 Mn |
| Dec 31, 2025 | 4.46 Mn |
| Sep 30, 2025 | 8.41 Mn |
| Sep 30, 2025 | 8.41 Mn |
| Jun 30, 2025 | 5.93 Mn |
| Jun 30, 2025 | 5.93 Mn |
| Mar 31, 2025 | 2.51 Mn |
| Mar 31, 2025 | 2.51 Mn |
| Dec 31, 2024 | 8.75 Mn |
| Dec 31, 2024 | 8.75 Mn |
| Sep 30, 2024 | 11.50 Mn |
| Sep 30, 2024 | 11.50 Mn |
| Jun 30, 2024 | 1.41 Mn |
| Jun 30, 2024 | 1.41 Mn |
| Mar 31, 2024 | 753,000.00 |
| Mar 31, 2024 | 753,000.00 |
| Dec 31, 2023 | 6.71 Mn |
| Dec 31, 2023 | 6.71 Mn |